Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥16,892 | CN¥20,546 | CN¥26,440 | CN¥28,767 |
| - Cash | CN¥6,999 | CN¥3,064 | CN¥4,591 | CN¥1,711 |
| + Debt | CN¥7,304 | CN¥1,624 | CN¥1,820 | CN¥1,373 |
| Enterprise Value | CN¥17,196 | CN¥19,105 | CN¥23,668 | CN¥28,429 |
| Revenue | CN¥8,547 | CN¥8,824 | CN¥13,039 | CN¥9,987 |
| % Growth | -3.1% | -32.3% | 30.6% | – |
| Gross Profit | CN¥537 | CN¥2,001 | CN¥5,547 | CN¥4,113 |
| % Margin | 6.3% | 22.7% | 42.5% | 41.2% |
| EBITDA | CN¥924 | CN¥2,410 | CN¥5,400 | CN¥4,282 |
| % Margin | 10.8% | 27.3% | 41.4% | 42.9% |
| Net Income | CN¥31 | CN¥1,283 | CN¥3,807 | CN¥3,018 |
| % Margin | 0.4% | 14.5% | 29.2% | 30.2% |
| EPS Diluted | 0.004 | 0.147 | 0.438 | 0.358 |
| % Growth | -97.5% | -66.3% | 22.3% | – |
| Operating Cash Flow | CN¥468 | CN¥80 | CN¥2,644 | CN¥3,197 |
| Capital Expenditures | -CN¥1,116 | -CN¥829 | -CN¥936 | -CN¥1,735 |
| Free Cash Flow | -CN¥648 | -CN¥748 | CN¥1,708 | CN¥1,462 |